This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (57)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Psychosocial Issues  • Psychopharmacology  • Psychotherapy  • Public Health  • Alert me on articles by topic

Sharon M. Hall, PhD; Gary L. Humfleet, PhD; Victor I. Reus, MD; Ricardo F. Muñoz, PhD; Diane T. Hartz, PhD; Roland Maude-Griffin, BA

Arch Gen Psychiatry. 2002;59:930-936.

Background  Sustained-release bupropion hydrochloride and nortriptyline hydrochloride have been shown to be efficacious in the treatment of cigarette smoking. It is not known whether psychological intervention increases the efficacy of these antidepressants. This study compared both drugs with placebo. It also examined the efficacy of these 2 drugs and placebo with and without psychological intervention.

Methods  This was a 2 (medical management vs psychological intervention) x 3 (bupropion vs nortriptyline vs placebo) randomized trial. Participants were 220 cigarette smokers. Outcome measures were biologically verified abstinence from cigarettes at weeks 12, 24, 36, and 52.

Results  Psychological intervention produced higher 7-day point-prevalence rates of biochemically verified abstinence than did medical management alone. With the use of point-prevalence abstinence, both nortriptyline and bupropion were more efficacious than placebo. On rates of 1-year continuous abstinence, the 2 drugs did not differ from each other or from placebo. Psychological intervention did not differ from medical management alone on rates of 1-year continuous abstinence.

Conclusions  Both nortriptyline and bupropion are efficacious in producing abstinence in cigarette smokers. Similarly, psychological intervention produces better abstinence rates than simple medical management. Both drugs, and psychological intervention, have limited efficacy in producing sustained abstinence. The data also suggest that combined psychological intervention and antidepressant drug treatment may not be more effective than antidepressant drug treatment alone.

From the Department of Psychiatry, University of California, San Francisco (Drs Hall, Humfleet, Reus, Muñoz, and Hartz); and Edina, Minn (Mr Maude-Griffin).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials
Eisenberg et al.
CMAJ 2008;179:135-144.
ABSTRACT | FULL TEXT  

Treatment for Cigarette Smoking Among Depressed Mental Health Outpatients: A Randomized Clinical Trial
Hall et al.
Am. J. Public Health 2006;96:1808-1814.
ABSTRACT | FULL TEXT  

Efficacy of Bupropion and Nortriptyline for Smoking Cessation Among People at Risk for or With Chronic Obstructive Pulmonary Disease
Wagena et al.
Arch Intern Med 2005;165:2286-2292.
ABSTRACT | FULL TEXT  

Improving the Rates of Quitting Smoking for Veterans With Posttraumatic Stress Disorder
McFall et al.
Am. J. Psychiatry 2005;162:1311-1319.
ABSTRACT | FULL TEXT  

A Randomized Trial of Nortriptyline Combined With Transdermal Nicotine for Smoking Cessation
Prochazka et al.
Arch Intern Med 2004;164:2229-2233.
ABSTRACT | FULL TEXT  

Extended Nortriptyline and Psychological Treatment for Cigarette Smoking
Hall et al.
Am. J. Psychiatry 2004;161:2100-2107.
ABSTRACT | FULL TEXT  

Tobacco Cessation in Primary Care: Maximizing Intervention Strategies
Anczak and Nogler
Clin Med Res 2003;1:201-216.
ABSTRACT | FULL TEXT  

Smoking Cessation: Medications Work, but for How Long?
JWatch Psychiatry 2003;2003:12-12.
FULL TEXT  

Smoking Cessation: Medications Work, but for How Long?
JWatch Women's Health 2002;2002:1-1.
FULL TEXT